vs
Side-by-side financial comparison of NWPX Infrastructure, Inc. (NWPX) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
NWPX Infrastructure, Inc. is the larger business by last-quarter revenue ($138.3M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 19.1%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 3.3%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NWPX vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.3M | $75.5M |
| Net Profit | $10.5M | — |
| Gross Margin | 19.3% | 69.3% |
| Operating Margin | 9.2% | 22.7% |
| Net Margin | 7.6% | — |
| Revenue YoY | 19.1% | 27.7% |
| Net Profit YoY | 165.7% | — |
| EPS (diluted) | $1.08 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $138.3M | — | ||
| Q4 25 | $125.6M | $75.5M | ||
| Q3 25 | $151.1M | $54.5M | ||
| Q2 25 | $133.2M | $52.4M | ||
| Q1 25 | $116.1M | $46.0M | ||
| Q4 24 | $119.6M | $59.1M | ||
| Q3 24 | $130.2M | $80.5M | ||
| Q2 24 | $129.5M | $47.1M |
| Q1 26 | $10.5M | — | ||
| Q4 25 | $8.9M | — | ||
| Q3 25 | $13.5M | $8.8M | ||
| Q2 25 | $9.1M | $5.9M | ||
| Q1 25 | $4.0M | $3.0M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $10.3M | $20.3M | ||
| Q2 24 | $8.6M | $-4.5M |
| Q1 26 | 19.3% | — | ||
| Q4 25 | 21.3% | 69.3% | ||
| Q3 25 | 21.3% | 77.7% | ||
| Q2 25 | 19.0% | 76.5% | ||
| Q1 25 | 16.7% | 77.1% | ||
| Q4 24 | 18.8% | 76.4% | ||
| Q3 24 | 20.8% | 63.9% | ||
| Q2 24 | 19.9% | 77.4% |
| Q1 26 | 9.2% | — | ||
| Q4 25 | 10.4% | 22.7% | ||
| Q3 25 | 12.6% | 17.6% | ||
| Q2 25 | 9.9% | 12.7% | ||
| Q1 25 | 4.8% | 8.7% | ||
| Q4 24 | 8.8% | 22.6% | ||
| Q3 24 | 11.9% | 27.4% | ||
| Q2 24 | 10.5% | -4.6% |
| Q1 26 | 7.6% | — | ||
| Q4 25 | 7.1% | — | ||
| Q3 25 | 8.9% | 16.2% | ||
| Q2 25 | 6.8% | 11.2% | ||
| Q1 25 | 3.4% | 6.5% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 7.9% | 25.2% | ||
| Q2 24 | 6.7% | -9.6% |
| Q1 26 | $1.08 | — | ||
| Q4 25 | $0.88 | $0.26 | ||
| Q3 25 | $1.38 | $0.17 | ||
| Q2 25 | $0.91 | $0.12 | ||
| Q1 25 | $0.39 | $0.06 | ||
| Q4 24 | $1.00 | $0.40 | ||
| Q3 24 | $1.02 | $0.41 | ||
| Q2 24 | $0.86 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.3M | $97.5M |
| Total DebtLower is stronger | $10.7M | $22.7M |
| Stockholders' EquityBook value | $403.7M | $130.3M |
| Total Assets | $634.1M | $216.3M |
| Debt / EquityLower = less leverage | 0.03× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $14.3M | — | ||
| Q4 25 | $2.3M | $97.5M | ||
| Q3 25 | $2.7M | $94.4M | ||
| Q2 25 | $2.0M | $96.0M | ||
| Q1 25 | $5.3M | $93.2M | ||
| Q4 24 | $5.0M | $101.0M | ||
| Q3 24 | $5.7M | $96.7M | ||
| Q2 24 | $4.5M | $96.8M |
| Q1 26 | $10.7M | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
| Q1 26 | $403.7M | — | ||
| Q4 25 | $394.8M | $130.3M | ||
| Q3 25 | $386.4M | $115.3M | ||
| Q2 25 | $379.5M | $104.7M | ||
| Q1 25 | $378.5M | $97.1M | ||
| Q4 24 | $374.0M | $92.1M | ||
| Q3 24 | $362.4M | $71.1M | ||
| Q2 24 | $351.2M | $48.5M |
| Q1 26 | $634.1M | — | ||
| Q4 25 | $579.6M | $216.3M | ||
| Q3 25 | $605.2M | $202.9M | ||
| Q2 25 | $592.6M | $194.9M | ||
| Q1 25 | $582.2M | $196.2M | ||
| Q4 24 | $589.7M | $213.3M | ||
| Q3 24 | $617.2M | $220.7M | ||
| Q2 24 | $631.7M | $205.0M |
| Q1 26 | 0.03× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.3M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 2.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $29.3M | — | ||
| Q4 25 | $36.0M | $14.4M | ||
| Q3 25 | $21.0M | $9.7M | ||
| Q2 25 | $5.4M | $14.1M | ||
| Q1 25 | $4.8M | $3.6M | ||
| Q4 24 | $36.1M | $15.6M | ||
| Q3 24 | $22.7M | $11.0M | ||
| Q2 24 | $22.3M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $30.8M | $14.4M | ||
| Q3 25 | $13.2M | $9.7M | ||
| Q2 25 | $1.9M | $14.1M | ||
| Q1 25 | $1.2M | $3.6M | ||
| Q4 24 | $31.9M | $15.6M | ||
| Q3 24 | $16.8M | $11.0M | ||
| Q2 24 | $16.2M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 24.5% | 19.1% | ||
| Q3 25 | 8.7% | 17.7% | ||
| Q2 25 | 1.4% | 26.8% | ||
| Q1 25 | 1.0% | 7.7% | ||
| Q4 24 | 26.7% | 26.4% | ||
| Q3 24 | 12.9% | 13.7% | ||
| Q2 24 | 12.5% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 0.0% | ||
| Q3 25 | 5.2% | 0.0% | ||
| Q2 25 | 2.6% | 0.0% | ||
| Q1 25 | 3.2% | 0.1% | ||
| Q4 24 | 3.5% | 0.0% | ||
| Q3 24 | 4.6% | 0.0% | ||
| Q2 24 | 4.7% | 0.0% |
| Q1 26 | 2.78× | — | ||
| Q4 25 | 4.06× | — | ||
| Q3 25 | 1.55× | 1.10× | ||
| Q2 25 | 0.60× | 2.41× | ||
| Q1 25 | 1.22× | 1.21× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.22× | 0.54× | ||
| Q2 24 | 2.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NWPX
| Water Transmission Systems | $93.5M | 68% |
| Precast Infrastructure and Engineered Systems | $44.8M | 32% |
PBYI
Segment breakdown not available.
